ID

31851

Beschrijving

This ODM-file contains a form to fill in findings of the laboratory, serology and pregnancy testing. To be assessed at Day -1 of Period 1 and 2. Study ID: 106396 Clinical Study ID: TRX106396 Study Title: An open-label, randomized, single-dose, 2-period crossover study to evaluate sumatriptan pharmacokinetics for a TREXIMA™(sumatriptan 85mg and naproxen sodium 500mg)*, Tablet compared with an IMITREX® (sumatriptan) 100mg Tablet Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: sumatriptan Trade Name: Imitrex ,Imiject ,Imigran; Imitrex,Imiject,Imigran Study Indication: Migraine Disorders Sponsor: GlaxoSmithKline

Trefwoorden

Versies (2)

1. 03-10-18 03-10-18 -
2. 07-10-18 07-10-18 -

Houder van rechten

GlaxoSmithKline

Geüploaded op

3 oktober 2018

DOI

Voor een aanvraag inloggen.

Licentie